Results 131 to 140 of about 11,634 (196)

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2012
Los inhibidores de los receptores IIb/IIIa, un nuevo grupo de antiagregantes plaquetarios, son potentes bloqueadores del receptor que media la agregación plaquetaria y de ese modo bloquean la vía final común de la formación del trombo plaquetario.
Fidel Manuel Cáceres Lóriga, Horacio Pérez López   +1 more
doaj  

Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention [PDF]

, 2017
Todd Golden, Sehem Ghazala, Rita Wadeea, Shilpa Junna   +3 more
openalex   +1 more source

Adverse Drug Effect Profiles of Gp2b/3a Inhibitors: A Comparative Review of the Last Two Decades. [PDF]

Cureus, 2023
Hasan N, Jauregui W, Zubair M, Pushparajan VK, Carson BJ, Attaluri DM, Dixon D, Jaisinghani A, Chuecos A, Ravichandran D.   +9 more
europepmc   +1 more source

Tirofiban-induced thrombocytopenia. [PDF]

Ann Med, 2023
Wang J, Zou D.
europepmc   +1 more source

Abciximab (ReoPro) Dosing Strategy for the Management of Acute Intraprocedural Thromboembolic Complications during Pipeline Flow Diversion Treatment of Intracranial Aneurysms [PDF]

, 2018
Li-Mei Lin, Bowen Jiang, Jessica K Campos, Narlin Beaty, Matthew T. Bender, Rafael J. Tamargo, Judy Huang, Geoffrey P. Colby, Alexander L. Coon   +8 more
openalex   +1 more source

abciximab

, 2001
山口 徹
openalex   +2 more sources

Are tirofiban and abciximab identical in efficacy? [PDF]

, 2005
Fahim Haider Jafary
openalex   +1 more source

Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up [PDF]

, 2007
Gilles Montalescot, David Antoniucci, Adnan Kastrati, F.-J. Neumann, Maria Borentain, Angela Migliorini, C. Boutron, Jean Collet, Éric Vicaut   +8 more
openalex   +1 more source

Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature. [PDF]

J Clin Med
Kosowski M, Kocjan M, Mazurkiewicz M, Gamrot-Wrzoł M, Ryl S, Nowakowski K, Kawecki J, Kukulski T, Kawecki D, Morawiec-Migas B.   +9 more
europepmc   +1 more source

Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients [PDF]

, 2017
Krishnaraj S. Rathod, Sotiris Antoniou, Parizad Avari, Nannan Ding, P Wright, C Knight, Arun K. Jain, Anthony Mathur, EJ Smith, Roshan Weerackody, Andrew Wragg, Daniel A. Jones   +11 more
openalex   +1 more source